These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9794410)

  • 1. Active sites in complement component C3 mapped by mutations at indels.
    Ogata RT; Ai R; Low PJ
    J Immunol; 1998 Nov; 161(9):4785-94. PubMed ID: 9794410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family.
    Low PJ; Ai R; Ogata RT
    J Immunol; 1999 Jun; 162(11):6580-8. PubMed ID: 10352274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-inhibiting peptides identified by proximity to indels in the C3/4/5 protein family.
    Ogata RT; Low PJ
    J Immunol; 1997 Apr; 158(8):3852-60. PubMed ID: 9103453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary structure of cobra complement component C3.
    Fritzinger DC; Petrella EC; Connelly MB; Bredehorst R; Vogel CW
    J Immunol; 1992 Dec; 149(11):3554-62. PubMed ID: 1431125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third component of trout complement. cDNA cloning and conservation of functional sites.
    Lambris JD; Lao Z; Pang J; Alsenz J
    J Immunol; 1993 Dec; 151(11):6123-34. PubMed ID: 8245455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of human complement component C3 with factor B and with complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) involve an acidic sequence at the N-terminus of C3 alpha'-chain.
    Taniguchi-Sidle A; Isenman DE
    J Immunol; 1994 Dec; 153(11):5285-302. PubMed ID: 7963581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
    Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
    Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of residues in the C3dg region of human complement component C3 corresponding to a proposed binding site for complement receptor type 2 (CR2, CD21) does not abolish binding of iC3b or C3dg to CR2.
    Diefenbach RJ; Isenman DE
    J Immunol; 1995 Mar; 154(5):2303-20. PubMed ID: 7868901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutagenesis of the region around Cys-241 of complement component C2. Evidence for a C4b binding site.
    Horiuchi T; Macon KJ; Engler JA; Volanakis JE
    J Immunol; 1991 Jul; 147(2):584-9. PubMed ID: 2071895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third component of Xenopus complement: cDNA cloning, structural and functional analysis, and evidence for an alternate C3 transcript.
    Lambris JD; Pappas J; Mavroidis M; Wang Y; Manzone H; Schwager J; Du Pasquier L; Silibovsky R; Swager J [corrected to Schwager J]
    Eur J Immunol; 1995 Feb; 25(2):572-8. PubMed ID: 7875221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of arginine 462 and the flanking sequence of human C4 beta-chain in mediating C5 binding to the C4b subcomponent of the classical complement pathway C5 convertase.
    Ebanks RO; Isenman DE
    J Immunol; 1995 Mar; 154(6):2808-20. PubMed ID: 7876551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 convertases of complement. Molecular genetics, structure and function of the catalytic domains, C2 and B.
    Volanakis JE
    Year Immunol; 1989; 4():218-30. PubMed ID: 2648703
    [No Abstract]   [Full Text] [Related]  

  • 14. Distal recognition site for classical pathway convertase located in the C345C/netrin module of complement component C5.
    Sandoval A; Ai R; Ostresh JM; Ogata RT
    J Immunol; 2000 Jul; 165(2):1066-73. PubMed ID: 10878385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of human C3/cobra venom factor hybrid proteins for therapeutic complement depletion.
    Fritzinger DC; Hew BE; Thorne M; Pangburn MK; Janssen BJ; Gros P; Vogel CW
    Dev Comp Immunol; 2009; 33(1):105-16. PubMed ID: 18760301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of human complement component C3 for catalytic inhibition of complement.
    Kölln J; Bredehorst R; Spillner E
    Immunol Lett; 2005 Apr; 98(1):49-56. PubMed ID: 15790508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
    Rehana S; Manjunatha Kini R
    Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxiagin from the Naja oxiana cobra venom is the first reprolysin inhibiting the classical pathway of complement.
    Shoibonov BB; Osipov AV; Kryukova EV; Zinchenko AA; Lakhtin VM; Tsetlin VI; Utkin YN
    Mol Immunol; 2005 Jun; 42(10):1141-53. PubMed ID: 15829304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cloning and protein analysis of divergent forms of the complement component C3 from a bony fish, the common carp (Cyprinus carpio): presence of variants lacking the catalytic histidine.
    Nakao M; Mutsuro J; Obo R; Fujiki K; Nonaka M; Yano T
    Eur J Immunol; 2000 Mar; 30(3):858-66. PubMed ID: 10741402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.